RICHMOND, Va., Dec. 22 /PRNewswire/ -- The organizers of the Mid-Atlantic Bio conference moved swiftly to capitalize on the positive momentum gained from the 2005 event by announcing plans for the conference next fall. More than 675 individuals from 20 states and 5 countries attended this year’s event, establishing Mid-Atlantic Bio as the premier industry and investor conference for the region. Attendees represented more than 200 industry companies, 50 investors and 60 program speakers. The 2006 event will take place October 10th and 11th at the Ronald Reagan Building and International Trade Center in the heart of Washington, D.C.
Inaugural Event Supporters Pleased; Support Lining Up Early for Year Two
“We were thrilled with the industry turnout and support for this inaugural event,” said Joel Marcus, CEO of Alexandria Real Estate Equities, a Diamond Sponsor of the 2005 conference. “There are clear advantages to bringing the industry together in one place on a regional level and those in attendance found the conference and networking functions beneficial for the long term.” Alexandria Real Estate Equities has confirmed their return as a Diamond Sponsor for the 2006 event.
Mid-Atlantic Bio is the result of collaboration between industry organizations and leaders throughout the region. It is a one-of-a-kind conference and exhibition environment creating a unique venue for bioscience companies to network, educate and partner with colleagues. The conference is a jointly hosted event for bioscience companies, academia, and the investor community, combining the most beneficial aspects of a regional industry meeting and investor conference -- all with the unified goal of advancing the growth of bioscience in the Mid-Atlantic region.
Industry Participation Strong; Programming Substantive
“It’s so important for companies like ours to create and maintain contacts both within the investor community and among our industry. This year’s event was a success on both counts,” remarked Gary Altman of Sequoia Pharmaceuticals, one of the presenting companies selected in 2005 to tell their story to investors and industry colleagues.
Among the 2005 highlights were 13 breakout and 3 plenary sessions on a wide range of issues impacting the bioscience industry, company presentations to venture capital groups, and private networking functions.
Mid-Atlantic Bio is hosted by four of the region’s most influential bioscience and investor associations: Mid-Atlantic Venture Association (MAVA), MdBio, Tech Council of Maryland and the Virginia Biotechnology Association (VaBIO).
For more information about the 2006 Mid-Atlantic Bio conference, please visit http://www.midatlanticbio.org.
Virginia Biotechnology Association
CONTACT: Mark Herzog of the Virginia Biotechnology Association,+1-804-643-6360, or mherzog@vabio.org